Data Interoperability for Ambulatory Monitoring of Cardiovascular Disease: A Scientific Statement From the American Heart Association
Overview
Genetics
Authors
Affiliations
Wearable devices are increasingly used by a growing portion of the population to track health and illnesses. The data emerging from these devices can potentially transform health care. This requires an interoperability framework that enables the deployment of platforms, sensors, devices, and software applications within diverse health systems, aiming to facilitate innovation in preventing and treating cardiovascular disease. However, the current data ecosystem includes several noninteroperable systems that inhibit such objectives. The design of clinically meaningful systems for accessing and incorporating these data into clinical workflows requires strategies to ensure the quality of data and clinical content and patient and caregiver accessibility. This scientific statement aims to address the best practices, gaps, and challenges pertaining to data interoperability in this area, with considerations for (1) data integration and the scope of measures, (2) application of these data into clinical approaches/strategies, and (3) regulatory/ethical/legal issues.
Addressing contemporary threats in anonymised healthcare data using privacy engineering.
Narayan S, Kohli N, Martin M NPJ Digit Med. 2025; 8(1):145.
PMID: 40050672 PMC: 11885643. DOI: 10.1038/s41746-025-01520-6.
Rytkin E, Zotova I, Passman R, Ardashev A, Trachiotis G, Efimov I J Interv Card Electrophysiol. 2025; .
PMID: 39863724 DOI: 10.1007/s10840-025-01994-0.
DeGroat W, Abdelhalim H, Peker E, Sheth N, Narayanan R, Zeeshan S Sci Rep. 2024; 14(1):26503.
PMID: 39489837 PMC: 11532369. DOI: 10.1038/s41598-024-78553-6.
Cardiovascular care with digital twin technology in the era of generative artificial intelligence.
Thangaraj P, Benson S, Oikonomou E, Asselbergs F, Khera R Eur Heart J. 2024; .
PMID: 39322420 PMC: 11638093. DOI: 10.1093/eurheartj/ehae619.